Search for Tradename: PATANOL

Summary for Tradename: PATANOL

Patents:	2
Applicants:	1
NDAs:	1
2009 Sales:	$187,599,000
Therapeutic Class:	Ophthalmic Agents

Latest news for PATANOL

Alcon's net profit up to $670 million in second quarter

26 July 2010, 10:13 pm

Alcon Posts 12.5 Percent Rise in Second Quarter Sales

26 July 2010, 4:15 pm

Courtesy of Yahoo News

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Product	Substance	Delist Req.	Patent Expiration	Exclusivity Expiration
Alcon	PATANOL	olopatadine hydrochloride	020688	Dec 18, 1996	RX	Yes	5,116,863*PED			Y	Jun 18, 2011
Alcon	PATANOL	olopatadine hydrochloride	020688	Dec 18, 1996	RX	Yes	5,641,805*PED			Y	Dec 6, 2015

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: PATANOL

Drugname	Dosage	Strength	RLD	Submissiondate
olopatadine hydrochloride	Ophthalmic Solution	0.10%	Patanol	7/17/2006

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
2000 2001 2002 2003 2004
2005 2006 2007 2008 2009

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...